Biomedical companies are increasingly looking for new ways to capitalize on accessible genomic sequencing technology, such as offering disease-specific genetic tests or portable sequencers that allow consumers to analyze their genetic data from anywhere, according to MIT Technology Review.
Here are five companies leading the personalized genomics industry, based on MIT Technology Review's 50 Smartest Companies 2017 list.
1. Mountain View, Calif.-based 23andMe, a direct-to-consumer health and ancestry DNA-testing service
2. San Diego-based Illumina, which creates sequencing and array-based technologies to advance life science research
3. Oxford (U.K.) Nanopore, the makers of a handheld sequencer for on-the-go DNA decoding
4. Saint Sulpice, Switzerland-based Sophia Genetics, an analytics platform for clinical genomics
5. Danvers, Mass.-based Veritas Genetics, which develops and offers whole-genome sequencing
More articles on health IT:
March on Google called off following 'credible threats'
Sutherland Healthcare selects Dr. Shailja Dixit as CMO: 3 points
Fundraiser supporting legal defense of cyber researcher pulled, donations from stolen credit cards